[Comparative analysis of insulin glargine vs. insulin detemir: A cost-minimization study applicable to Colombia].
CONCLUSIONS: As only medication costs are considered, differences in insulin units between IG and ID result in a differential cost in favor of IG that makes it a cost/effective alternative.
PMID: 26535542 [PubMed - in process]
Source: Biomedica : Revista del Instituto Nacional de Salud - Category: Global & Universal Tags: Biomedica Source Type: research
More News: Clinical Trials | Colombia Health | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Endocrinology | Insulin | International Medicine & Public Health | Lantus | Levemir | Study